Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

1.

Proton-beam therapy for olfactory neuroblastoma.

Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M, Katsuta S, Nishio T.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):758-62. Epub 2007 Mar 29.

PMID:
17398027
[PubMed - indexed for MEDLINE]
2.

[Clinical analysis of 10 cases of olfactory neuroblastoma].

Wang HL, Fan GK, Lin ZH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Jan;38(1):103-6. Chinese.

PMID:
19253437
[PubMed - indexed for MEDLINE]
3.

Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.

Diaz EM Jr, Johnigan RH 3rd, Pero C, El-Naggar AK, Roberts DB, Barker JL, DeMonte F.

Head Neck. 2005 Feb;27(2):138-49.

PMID:
15654688
[PubMed - indexed for MEDLINE]
4.

Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.

Gruber G, Laedrach K, Baumert B, Caversaccio M, Raveh J, Greiner R.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):486-91.

PMID:
12243826
[PubMed - indexed for MEDLINE]
5.

Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses.

Zenda S, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M, Hayashi R, Kishimoto S, Ogino T.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1473-8. doi: 10.1016/j.ijrobp.2010.08.009. Epub 2010 Oct 18.

PMID:
20961697
[PubMed - indexed for MEDLINE]
6.

Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.

Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, Hashimoto T, Mizumoto M, Ohara K, Akine Y.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):786-93. Epub 2007 Mar 26.

PMID:
17379439
[PubMed - indexed for MEDLINE]
7.

Treatment of olfactory neuroblastoma. A report of 11 cases.

Jekunen AP, Kairemo KJ, Lehtonen HP, Kajanti MJ.

Am J Clin Oncol. 1996 Aug;19(4):375-8. Review.

PMID:
8677908
[PubMed - indexed for MEDLINE]
8.

Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.

Constantinidis J, Steinhart H, Koch M, Buchfelder M, Schaenzer A, Weidenbecher M, Iro H.

Otolaryngol Head Neck Surg. 2004 May;130(5):567-74.

PMID:
15138422
[PubMed - indexed for MEDLINE]
9.

Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.

Kim HJ, Kim CH, Lee BJ, Chung YS, Kim JK, Choi YS, Yoon JH.

Auris Nasus Larynx. 2007 Dec;34(4):493-8. Epub 2007 May 11.

PMID:
17499464
[PubMed - indexed for MEDLINE]
10.

Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.

Fukumitsu N, Okumura T, Mizumoto M, Oshiro Y, Hashimoto T, Kanemoto A, Hashii H, Ohkawa A, Moritake T, Tsuboi K, Tabuchi K, Wada T, Hara A, Sakurai H.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):704-11. doi: 10.1016/j.ijrobp.2011.07.032. Epub 2011 Nov 16.

PMID:
22099036
[PubMed - indexed for MEDLINE]
11.

Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.

Hata M, Tokuuye K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Ohara K, Matsuzaki Y, Tanaka N, Akine Y.

Cancer. 2005 Aug 15;104(4):794-801.

PMID:
15981284
[PubMed - indexed for MEDLINE]
Free Article
12.

Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Tokita M, Abei M, Shoda J, Matsuzaki Y, Thono E, Tsuboi K, Tokuuye K.

Strahlenther Onkol. 2009 Dec;185(12):782-8. doi: 10.1007/s00066-009-2020-x. Epub .

PMID:
20013087
[PubMed - indexed for MEDLINE]
13.

High-dose proton beam therapy for Stage I non-small-cell lung cancer.

Nihei K, Ogino T, Ishikura S, Nishimura H.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):107-11. Epub 2006 Feb 3.

PMID:
16458447
[PubMed - indexed for MEDLINE]
14.

Combined modality therapy of esthesioneuroblastoma.

McLean JN, Nunley SR, Klass C, Moore C, Müller S, Johnstone PA.

Otolaryngol Head Neck Surg. 2007 Jun;136(6):998-1002.

PMID:
17547995
[PubMed - indexed for MEDLINE]
15.

Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.

Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Matzinger O, Zouhair A.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):992-7. doi: 10.1016/j.ijrobp.2009.09.019. Epub 2010 Mar 16.

PMID:
20231062
[PubMed - indexed for MEDLINE]
16.

Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy.

Fitzek MM, Thornton AF, Varvares M, Ancukiewicz M, Mcintyre J, Adams J, Rosenthal S, Joseph M, Amrein P.

Cancer. 2002 May 15;94(10):2623-34.

PMID:
12173330
[PubMed - indexed for MEDLINE]
17.

High dose level radiation therapy for local tumour control in esthesioneuroblastoma.

Guedea F, Van Limbergen E, Van den Bogaert W.

Eur J Cancer. 1994;30A(12):1757-60.

PMID:
7880600
[PubMed - indexed for MEDLINE]
18.

The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma.

Zabel A, Thilmann C, Milker-Zabel S, Schlegel W, Zuna I, Wannenmacher M, Debus J.

Strahlenther Onkol. 2002 Apr;178(4):187-91.

PMID:
12040755
[PubMed - indexed for MEDLINE]
19.

Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.

Eich HT, Hero B, Staar S, Micke O, Seegenschmiedt H, Mattke A, Berthold F, Müller RP.

Strahlenther Onkol. 2003 Apr;179(4):233-40.

PMID:
12707712
[PubMed - indexed for MEDLINE]
20.

Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.

Weber DC, Rutz HP, Pedroni ES, Bolsi A, Timmermann B, Verwey J, Lomax AJ, Goitein G.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):401-9.

PMID:
16168833
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk